Expression profiles of short-term fibroblasts have previously been reported to separate carriers of a heterozygous mutation in the BRCA1 or BRCA2 genes from sporadic breast-cancer-affected controls [30],[31]. The gene discussed is BRCA2; the disease is breast cancer.